Impact of Tonsillectomy on Obesity in Pediatric Patients With Sleep-Disordered Breathing

Rohith S Voora1,2, Daniela Carvalho2,3, Wen Jiang2,3

  • 1School of Medicine, University of California, San Diego, San Diego, California, USA.

OTO Open
|December 6, 2021
PubMed

Insights

Pediatric tonsillectomy for sleep-disordered breathing (SDB) is associated with a significant increase in body mass index (BMI) percentile. This finding highlights the need for obesity management counseling and follow-up for children undergoing this surgery.

Area of Science:

  • Pediatric Otolaryngology
  • Pediatric Endocrinology
  • Sleep Medicine

Background:

  • Tonsillar hypertrophy and obesity are key contributors to pediatric sleep-disordered breathing (SDB).
  • Tonsillectomy is a common surgical intervention for SDB, addressing airway obstruction.
  • Potential adverse effects of tonsillectomy on pediatric obesity profiles warrant investigation.

Purpose of the Study:

  • To investigate changes in body mass index (BMI) percentile in pediatric patients following tonsillectomy.
  • To analyze the relationship between preoperative and postoperative BMI in children undergoing tonsillectomy for SDB.

Main Methods:

  • Retrospective case series conducted at a tertiary pediatric academic center.
  • Included 1153 pediatric patients undergoing tonsillectomy between January 2016 and December 2016.
  • Utilized generalized regression modeling to analyze BMI percentile changes, considering age, sex, and surgical indication.

Main Results:

  • A significant increase in median BMI percentile was observed post-tonsillectomy (65.8 to 76.4).
  • Higher preoperative BMI percentile, younger age, male sex, and SDB indication correlated with increased postoperative BMI percentile.
  • 48.6% of the cohort had available follow-up BMI data, with a median follow-up of 197 days.

Conclusions:

  • Tonsillectomy is associated with a significant increase in BMI percentile in pediatric patients.
  • A higher proportion of patients were classified as overweight or obese postoperatively.
  • Enhanced preoperative counseling and adjunctive obesity management strategies are recommended for pediatric patients undergoing tonsillectomy.
Abstract

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
6.1K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
680
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
194
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
239
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
13
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
13